KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Gross Profit (2016 - 2025)

Opko Health (OPK) has disclosed Gross Profit for 16 consecutive years, with $64.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 24.37% year-over-year to $64.0 million, compared with a TTM value of $205.9 million through Dec 2025, up 198.56%, and an annual FY2025 reading of $205.9 million, down 5.75% over the prior year.
  • Gross Profit was $64.0 million for Q4 2025 at Opko Health, up from $49.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $417.3 million in Q2 2021 and bottomed at -$1.5 billion in Q4 2022.
  • Average Gross Profit over 5 years is $37.8 million, with a median of $51.6 million recorded in 2022.
  • The sharpest move saw Gross Profit plummeted 485.64% in 2022, then skyrocketed 541.89% in 2023.
  • Year by year, Gross Profit stood at $380.3 million in 2021, then tumbled by 485.64% to -$1.5 billion in 2022, then soared by 96.34% to -$53.7 million in 2023, then soared by 257.73% to $84.7 million in 2024, then fell by 24.37% to $64.0 million in 2025.
  • Business Quant data shows Gross Profit for OPK at $64.0 million in Q4 2025, $49.9 million in Q3 2025, and $49.4 million in Q2 2025.